NIH chief snubs Bush stem cell policy
Can President Bush’s weakening hold on Washington bureaucracy be detected in its bioethics? The head of the National Institutes of Health, Elias Zerhouni, has again contradicted his boss’s stand on stem cell research. In the latest issue of a popular magazine published by the NIH, Medline Plus, Dr Zerhouni argues strongly for expanding research on human embryos. “All avenues of research need to be pursued. We must continue the research at all levels, or there will be no progress,” he writes.
Dr Zerhouni told a Congressional committee in March that current restrictions on embryonic stem cell research ought to be lifted. A White House spokesman responded that the President had to take a “broader view” than a scientist, including “moral and religious views”.
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...